Pattern and course of neurodegeneration in Langerhans cell histiocytosis.

[1]  D. Prayer,et al.  Long-Term MR Imaging Course of Neurodegenerative Langerhans Cell Histiocytosis , 2007, American Journal of Neuroradiology.

[2]  D. Prayer,et al.  Central nervous system‐related permanent consequences in patients with Langerhans cell histiocytosis , 2007, Pediatric blood & cancer.

[3]  R. Guillevin,et al.  MRI features of neurodegenerative Langerhans cell histiocytosis , 2006, European Radiology.

[4]  U. Pötschger,et al.  Risk factors for diabetes insipidus in langerhans cell histiocytosis , 2006, Pediatric blood & cancer.

[5]  D. Prayer,et al.  Neuropathology of CNS disease in Langerhans cell histiocytosis. , 2005, Brain : a journal of neurology.

[6]  D. Prayer,et al.  Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis , 2004, Pediatric blood & cancer.

[7]  K. Hoang-Xuan,et al.  Retinoic acid therapy in “degenerative‐like” neuro‐langerhans cell histiocytosis: A prospective pilot study , 2004, Pediatric blood & cancer.

[8]  A. Barkovich,et al.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis. , 2004, AJNR. American journal of neuroradiology.

[9]  R. Egeler,et al.  Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society—Late Effects Study Group , 2004, Pediatric blood & cancer.

[10]  K. Hoang-Xuan,et al.  Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. , 2004, The Journal of pediatrics.

[11]  P. Hogendoorn,et al.  Langerhans-cell histiocytosis 'insight into DC biology'. , 2003, Trends in immunology.

[12]  B. Trapp,et al.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease , 2003, Journal of the Neurological Sciences.

[13]  A. Polizzi,et al.  Acute ataxia complicating Langherans cell histiocytosis , 2002, Archives of disease in childhood.

[14]  J. Michaelis,et al.  A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. , 2001, The Journal of pediatrics.

[15]  J. Pritchard,et al.  Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis , 2000, Clinical endocrinology.

[16]  J. Donadieu,et al.  Langerhans Cell Histiocytosis and the Central Nervous System in Childhood: Evolution and Prognostic Factors. Results of a Collaborative Study , 2000, Journal of child neurology.

[17]  I. Saatci,et al.  Cerebellar and basal ganglion involvement in Langerhans cell histiocytosis , 1999, Neuroradiology.

[18]  R. Arceci.  The histiocytoses: the fall of the Tower of Babel. , 1999, European journal of cancer.

[19]  D. Prayer,et al.  Central nervous system disease in Langerhans cell histiocytosis. , 1998, Hematology/oncology clinics of North America.

[20]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[21]  A. Barkovich,et al.  Central nervous system disease in Langerhans cell histiocytosis. , 1994, The British journal of cancer. Supplement.

[22]  W. Bradley.  Recent views on amyotrophic lateral sclerosis with emphasis on electrophysiological studies , 1987, Muscle & nerve.

[23]  U. Bode,et al.  [Langerhans cell histiocytosis in childhood--results of the DAL-HX 83 study]. , 1987, Klinische Padiatrie.

[24]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[25]  A. Hand.  DEFECTS OF MEMBRANOUS BONES, EXOPHTHALMOS AND POLYURIA IN CHILDHO0D: IS IT DYSPITUITARISM? , 1921 .

[26]  J. Emile,et al.  [Langerhans cell histiocytosis]. , 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[27]  H. Gadner,et al.  Treatment strategy for disseminated langerhans cell histiocytosis , 1994 .